Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2026.1782019 Correction Correction: RBM39 shapes innate immunity by controlling expression of key factors of the interferon response LiTeng-Feng 1 Visualization Conceptualization Writing – review & editing Writing – original draft Investigation RothhaarPaul 1 Visualization Writing – review & editing Investigation LangArthur 1 Writing – review & editing Investigation GrünvogelOliver 1 Visualization Writing – review & editing Methodology Conceptualization ColasantiOmbretta 1 Writing – review & editing Writing – original draft Methodology UgarteSanta Mariela Olivera 1 Investigation Writing – review & editing TrautJannik 1 Writing – review & editing Investigation Visualization Conceptualization PirasAntonio 2 Investigation Writing – review & editing Acosta-RiveroNelson 3 Writing – review & editing Methodology Gonçalves MagalhãesVladimir 4 Writing – review & editing Investigation SpringerEmely 5 Writing – review & editing Investigation BetzAndreas 1 Investigation Writing – review & editing HuangHao-En 1 Investigation Writing – review & editing ParkJeongbin 6 7 8 Writing – review & editing Investigation QiuRuiyue 9 Writing – review & editing Investigation GnouamoziGnimah Eva 3 Writing – review & editing Methodology MehnertAnn-Kathrin 10 Writing – review & editing Methodology Dao ThiViet Loan 10 11 Supervision Writing – review & editing UrbanStephan 3 11 Supervision Writing – review & editing MuckenthalerMartina 9 Writing – review & editing Supervision SchlesnerMatthias 6 12 Writing – review & editing Supervision WohlleberDirk 5 Writing – review & editing Supervision BinderMarco 4 Supervision Writing – review & editing BartenschlagerRalf 3 4 11 Writing – review & editing Supervision PichlmairAndreas 2 13 Supervision Writing – review & editing LohmannVolker 1 11 * Funding acquisition Project administration Writing – original draft Methodology Resources Conceptualization Supervision Writing – review & editing Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany Department of Infectious Diseases, Molecular Virology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany Division of Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany Institute of Molecular Immunology, University Hospital Klinikum rechts der Isar, Technical University of Munich, Munich, Germany Bioinformatics and Omics Data Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany Faculty of Biosciences, Heidelberg University, Heidelberg, Germany School of Biomedical Convergence Engineering, Pusan National University, Yangsan, Republic of Korea Heidelberg University, Medical Faculty, Department of Pediatric Oncology, Hematology, Immunology and Pneumology, Heidelberg, Germany Department of Infectious Diseases, Virology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany German Center for Infection Research (DZIF), Heidelberg Partner Site, Heidelberg, Germany Biomedical Informatics, Data Mining and Data Analytics, Faculty of Applied Computer Science and Medical Faculty, University of Augsburg, Augsburg, Germany German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany Correspondence: Volker Lohmann, Volker.Lohmann@med.uni-heidelberg.de 26 01 2026 2026 17 1782019 06 01 2026 07 01 2026 Copyright © 2026 Li, Rothhaar, Lang, Grünvogel, Colasanti, Ugarte, Traut, Piras, Acosta-Rivero, Gonçalves Magalhães, Springer, Betz, Huang, Park, Qiu, Gnouamozi, Mehnert, Dao Thi, Urban, Muckenthaler, Schlesner, Wohlleber, Binder, Bartenschlager, Pichlmair and Lohmann. 2026 Li, Rothhaar, Lang, Grünvogel, Colasanti, Ugarte, Traut, Piras, Acosta-Rivero, Gonçalves Magalhães, Springer, Betz, Huang, Park, Qiu, Gnouamozi, Mehnert, Dao Thi, Urban, Muckenthaler, Schlesner, Wohlleber, Binder, Bartenschlager, Pichlmair and Lohmann https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A Correction on RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response By Li T-F, Rothhaar P, Lang A, Grünvogel O, Colasanti O, Ugarte SMO, Traut J, Piras A, Acosta-Rivero N, Gonçalves Magalhães V, Springer E, Betz A, Huang H-E, Park J, Qiu R, Gnouamozi GE, Mehnert A-K, Thi VLD, Urban S, Muckenthaler M, Schlesner M, Wohlleber D, Binder M, Bartenschlager R, Pichlmair A and Lohmann V (2025) Front. Immunol. 16:1568056. doi: 10.3389/fimmu.2025.1568056 RBM39 IRF3 STAT1 STAT2 IFNs splicing section-at-acceptance Molecular Innate Immunity

Affiliations “Faculty of Biosciences, Heidelberg University, Heidelberg, Germany” and “School of Biomedical Convergence Engineering, Pusan National University, Yangsan, Republic of Korea” were omitted from the paper. These affiliations have now been added for author Jeonbin Park.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland